News
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: init innovation in traffic systems SE (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Research update on init innovation in traffic systems SE by Quirin Privatbank Kapitalmarktgeschäft, confirming full year guidance. EUR 75.7m orders in Q1-25 with revenues of EUR 70.4m. EBIT at EUR 2.0m -
COMMUNIQUÉ DE PRESSE
Formycon and Fresenius Kabi announce FDA Approval of Interchangeability for FYB202/Otulfi® (ustekinumab-aauz)
Formycon and Fresenius Kabi receive FDA approval for interchangeability of FYB202/Otulfi (ustekinumab-aauz) with Stelara, enhancing patient access to treatment options for inflammatory diseases in the US -
COMMUNIQUÉ DE PRESSE
PL BioScience and DewCell sign LOI to Jointly Develop Artificial Human Platelets for Scalable, Animal-Free Cell Culture Media
PL BioScience and DewCell sign LOI to jointly develop artificial human platelets for scalable, animal-free cell culture media. The collaboration aims to meet demand driven by regulatory trends in cell- and gene therapy development -
COMMUNIQUÉ DE PRESSE
Interactive Strength Inc. (Nasdaq: TRNR) Updates FAQ's about Increasing 2025 Pro Forma Revenue Guidance to More Than $75M and Other Questions
Interactive Strength Inc. (Nasdaq:TRNR) raises its 2025 pro forma revenue guidance to over $75M. Read about the update and acquisition details on the Company's investor website and SEC filings -
-
-
-
-
COMMUNIQUÉ DE PRESSE
RLTR's Reel Intelligence (RI) Emerges as the Comprehensive Leader in Image Generation Surpassing Midjourney, Stable Diffusion, and Adobe Firefly
Reel Intelligence (RI) solidifies position as most advanced image generation solution, surpassing industry leaders in editing, video, research, and code development within an eco-efficient platform
